Alphatec Holdings, Inc. reported a significant increase in financial performance for the fiscal year ending December 31, 2025, with total revenue reaching $764.2 million, a 25% increase from $611.6 million in 2024. This growth was primarily driven by increased product volume and the expansion of the company's surgeon user base, alongside the adoption of its innovative spinal surgery technologies. The company continues to focus on enhancing its product portfolio, which includes spinal implants and medical imaging equipment, to address various spine disorders.
In terms of profitability, Alphatec's cost of sales rose to $232.3 million, reflecting a 24% increase compared to the previous year. Operating expenses also increased by 10% to $614.0 million, influenced by higher sales and administrative costs, as well as a notable rise in litigation-related expenses, which surged by 143% due to ongoing legal matters. Despite these increases, the company reported a net cash inflow from operating activities of $45.2 million, indicating improved cash generation capabilities.
Strategically, Alphatec has made significant advancements, including the launch of the EOS Insight software platform, which enhances surgical planning and post-operative assessment. The company has also expanded its geographic footprint, with initial surgeries performed in Australia, New Zealand, and Japan, contributing to its international growth strategy. The workforce has grown to 913 employees, with a focus on attracting skilled sales agents and direct representatives to enhance market penetration.
Looking ahead, Alphatec aims to continue its trajectory of growth by fostering surgeon adoption of its products through educational programs and expanding its sales network. The company has expressed confidence in its ability to achieve profitability, although it acknowledges the need for ongoing investment in research and development, as well as potential future funding requirements. The management remains committed to navigating the competitive landscape of the spinal surgery market while enhancing its operational efficiencies and product offerings.
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc. is a medical technology company specializing in the design and development of innovative surgical solutions for spine disorders. Its comprehensive product portfolio includes spinal implants, fixation systems, biologics, advanced imaging, neuromonitoring, and robotic navigation technologies. Serving spine surgeons, hospitals, and healthcare systems primarily in the U.S., Alphatec integrates proprietary procedures and informatics to improve surgical outcomes, safety, and efficiency through a holistic, approach-specific model.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.